References
- Slavin, S., Or, R., Naparstek, E., Eckerstein, A. and Weiss, L. (1988). Cellular mediated immunotherapy of leukemia in conjunction with autologous and allogeneic bone marrow transplantation in experimental animals and man. Blood, 72 (Suppl 1), 407a.
- Kolb, H. J., Mittermüller, J., Clemm, C. H. et al. (1990). Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76(12), 2462–2465.
- Kolb, H. J., Schattenberg, A., Goldman, J. M. et al. (1995). Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood, 86(5), 2041–2050.
- Drobyski, W. R., Keever, C. A., Roth, M. S. et al. (1993). Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose. Blood, 82, 2310–2318.
- Van Rhee, F. and Kolb, H. (1995). Donor Leukocyte transfusions in marrow grafted patients for leukemic relapse. Curr Opin Hematol., 2, 423–430.
- Boiron, J. M., Cony-Makhoul, P., Mahon, F. X., Pigneux, A., Puntous, M. and Reiffers, J. (1994). Treatment of Hematological Malignances Relapsing after Allogeneic Bone Marrow Transplantation. Blood Reviews, 8, 234–240.
- Shlomchik, W. D. and Emerson, S. G. (1996). The immunobiology of T Cell Therapies for Leukemias. Acta Haematologica, 96, 189–213.
- Slavin, S., Or, R., Kapelushnik, Y. et al. (1992). Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT). Leukemia, 6 (suppl 4), 164–166.
- Ferster, A., Bujan, W., Mouraux, T., Devalck, C. H., Heimann, P. and Sariban, E. (1994). Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant, 14, 331–332.
- Russell, L. A., Jacobsen, N., Heilmann, C., Simonsen, A. C., Christensen, L. D. and Vindelov, L. L. (1996). Treatment of relapse after allogeneic BMT with donor leukocyte infusions in 16 patients. Bone Marrow Transplant, 18, 411–414.
- Tzeng, C. H., Lin, J. S., Lee, J. C. I., Yung, C. H., Hu, H. Y. and Chen, P. M. (1996). Transfusion of donor peripheral blood buffy coat cells as effective treatment for relapsed acute leukemia after transplantation of allogeneic bone marrow or peripheral blood stem cells from the same donor. Transfusion, 36, 685–690.
- Slavin, S., Naparstek, E., Nagler, A. et al. (1995). Allogeneic cell-mediated immunotherapy of relapsed leukemia following BMT with donor peripheral blood lymphocytes and recombinant human interleukin-2. Exp Hematol., 23, 787(abstr.).
- Barret, A. J. and Malkovska, V. (1996). Graft-versus-leukaemia: Understanding and using the alloimmune response to treat haematological malignancies. Br. J. Haematol., 93, 754–761.
- Mavroudis, D. and Barret, J. (1996). The graft-versus-leukemia effect. Curr Opin Hematol., 3(6), 423–429.